149 related articles for article (PubMed ID: 11038760)
1. [Comprehensive treatment of bone metastases of breast cancer: a clinical analysis of 70 cases].
Zhou J; Zhang Q; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):284-6. PubMed ID: 11038760
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
Wang ZH; Xu BH
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of endocrine therapy and chemotherapy for bone metastasis of breast cancer].
Yan M; Song ST; Jiang ZF; Zhang SH; Liu XQ; Xu JM; Wang T; Luo WD
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):177-80. PubMed ID: 15196443
[TBL] [Abstract][Full Text] [Related]
4. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of combined-modality therapy for bone metastasis of non-small-cell lung cancer.
Li XX; Zhou TC; Zhao J
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):752-3. PubMed ID: 12865243
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of bone metastases in breast cancer].
Köhler AH; Dobberstein N; Stoltmann R; Heschel U
Zentralbl Chir; 1984; 109(7):483-9. PubMed ID: 6203258
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
8. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
[TBL] [Abstract][Full Text] [Related]
10. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective analysis of 98 cases of breast cancer with liver metastasis].
Zhu MQ; Zhang DS; Su ZY; Shi YX; Peng RJ; Zhou NN; Liu DG; Jiang WQ
Ai Zheng; 2007 Apr; 26(4):423-6. PubMed ID: 17430666
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study.
Cazzaniga ME; Dogliotti L; Cascinu S; Barni S; Labianca R; Chiara S; Conte PF; Gasparini G; Pasetto L; Torri V
Oncology; 2006; 71(5-6):374-81. PubMed ID: 17785994
[TBL] [Abstract][Full Text] [Related]
13. A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.
Cassier PA; Ray-Coquard I; Sunyach MP; Lancry L; Guastalla JP; Ferlay C; Gomez F; Curé H; Lortholary A; Claude L; Blay JY; Bachelot T
Cancer; 2008 Nov; 113(9):2532-8. PubMed ID: 18780315
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 67 patients with brain metastases from breast cancer].
He J; Feng FY; Xing PY; Wang XY; Zhang P
Ai Zheng; 2005 Dec; 24(12):1527-30. PubMed ID: 16351807
[TBL] [Abstract][Full Text] [Related]
15. [Survival and prognostic factors in radiation and combination therapy of bone metastases of breast cancer].
Shcherbenko OI
Med Radiol (Mosk); 1988 Apr; 33(4):36-40. PubMed ID: 3357390
[TBL] [Abstract][Full Text] [Related]
16. The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group.
Neave L; Harvey V; Benjamin C; Thompson P; Pellett O; Whitlock J; Jones W; Poole G;
N Z Med J; 2003 Oct; 116(1184):U648. PubMed ID: 14583806
[TBL] [Abstract][Full Text] [Related]
17. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
18. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
19. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
20. Microvascular density of breast cancer in bone metastasis: influence of therapy.
Lörincz T; Tóth J; Szendröi M; Tímár J
Anticancer Res; 2005; 25(4):3075-81. PubMed ID: 16080568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
